Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

Clicks: 465
ID: 120326
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #12 of 44 articles by views in archives of internal medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Approximately 400 patients were infected or colonized with carbapenem-resistant A baumannii and P aeruginosa during a 3-month period in 1999. A few strains have spread widely throughout hospitals in this region. The prevalence of resistant A baumannii seems to be correlated with cephalosporin use. M …
Reference Key
d2002archivescitywide Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S
Are you one of these authors? Claim your profile
Journal archives of internal medicine
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12090889
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Multicenter Study Incidence drug resistance multiple microbial sensitivity tests microbial pseudomonas infections / drug therapy* disease outbreaks* pseudomonas infections / microbiology* new york / epidemiology pseudomonas aeruginosa / drug effects ribotyping acinetobacter / genetics* carbapenems / therapeutic use pmid:12090889 doi:10.1001/archinte.162.13.1515 david landman john m quale steven brooks acinetobacter / drug effects acinetobacter / isolation & purification* acinetobacter infections / drug therapy* acinetobacter infections / microbiology* dna fingerprinting pseudomonas aeruginosa / genetics* pseudomonas aeruginosa / isolation & purification*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.